- Home
- Publications
- Publication Search
- Publication Details
Title
Modern pharmacological treatment of obese patients
Authors
Keywords
-
Journal
Therapeutic Advances in Endocrinology and Metabolism
Volume 11, Issue -, Pages 204201881989752
Publisher
SAGE Publications
Online
2020-01-22
DOI
10.1177/2042018819897527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Obesity and chemotherapy administration: between empiric and mathematic method review
- (2019) W. Bouleftour et al. ACTA ONCOLOGICA
- Updates on obesity pharmacotherapy
- (2018) Amanda Velazquez et al. Annals of the New York Academy of Sciences
- Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters
- (2018) Cornelis Smit et al. Expert Opinion on Drug Metabolism & Toxicology
- Phytoestrogen supplementation and body composition in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials
- (2018) Marija Glisic et al. MATURITAS
- Efficacy of adjuvant weight loss medication after bariatric surgery
- (2018) Zubaidah Nor Hanipah et al. Surgery for Obesity and Related Diseases
- Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
- (2018) Patrick M O'Neil et al. LANCET
- Anti-Obesity Therapy: from Rainbow Pills to Polyagonists
- (2018) T. D. Müller et al. PHARMACOLOGICAL REVIEWS
- Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
- (2018) Juan Pablo Frias et al. LANCET
- Pharmacotherapy of obesity: Available medications and drugs under investigation
- (2018) Eleni Pilitsi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes
- (2017) Melanie Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Liver Disease on Hepatic Transporter Expression and Function
- (2017) Nilay Thakkar et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Current pharmacotherapy for obesity
- (2017) Gitanjali Srivastava et al. Nature Reviews Endocrinology
- Efficacy and Safety of Cathine (Nor-Pseudoephedrine) in the Treatment of Obesity: A Randomized Dose-Finding Study
- (2017) Hans Hauner et al. Obesity Facts
- RYGB and Drug Disposition: How to Do Better? Analysis of Pharmacokinetic Studies and Recommendations for Clinical Practice
- (2017) Lorry Hachon et al. OBESITY SURGERY
- Management of obesity
- (2016) George A Bray et al. LANCET
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations
- (2016) Carmil Azran et al. Obesity Reviews
- Excess subcutaneous tissue may preclude intramuscular delivery when using adrenaline autoinjectors in patients with anaphylaxis
- (2015) J. Johnstone et al. ALLERGY
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis
- (2015) Juan Pablo Domecq et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug Dosing and Pharmacokinetics in Children With Obesity
- (2015) Margreet W. Harskamp-van Ginkel et al. JAMA Pediatrics
- Kidney function in severely obese adolescents undergoing bariatric surgery
- (2015) Nianzhou Xiao et al. Obesity
- The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis
- (2015) Jessica E. Potts et al. PLoS One
- Modern Obesity Pharmacotherapy: Weighing Cardiovascular Risk and Benefit
- (2014) Jonathan W. Cunningham et al. CLINICAL CARDIOLOGY
- Pharmacokinetics of Human Chorionic Gonadotropin Injection in Obese and Normal-Weight Women
- (2014) Divya K. Shah et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss
- (2014) Sonja K. Billes et al. PHARMACOLOGICAL RESEARCH
- Safety and Efficacy of Lorcaserin: A Combined Analysis of the BLOOM and BLOSSOM Trials
- (2014) Louis Aronne et al. POSTGRADUATE MEDICINE
- Different Time Trends of Caloric and Fat Intake Between Statin Users and Nonusers Among US Adults
- (2014) Takehiro Sugiyama et al. JAMA Internal Medicine
- Are IM injections IM in obese and overweight females? A study in injection technique
- (2013) Sara Palma et al. APPLIED NURSING RESEARCH
- Functional Alterations of Intestinal P-Glycoprotein under Diabetic Conditions
- (2013) Takuro Kobori et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials
- (2013) M. Monami et al. DIABETES OBESITY & METABOLISM
- The Influence of Bypass Procedures and Other Anatomical Changes in the Gastrointestinal Tract on the Oral Bioavailability of Drugs
- (2013) Julie De Smet et al. JOURNAL OF CLINICAL PHARMACOLOGY
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Possible risk factors for increased suicide following bariatric surgery
- (2013) James E. Mitchell et al. Obesity
- Influence of Bariatric Surgery on the Use and Pharmacokinetics of Some Major Drug Classes
- (2013) Jan Peter Yska et al. OBESITY SURGERY
- Weight Considerations in Psychotropic Drug Prescribing and Switching
- (2013) Mehrul Hasnain et al. POSTGRADUATE MEDICINE
- Antithrombotic therapy in obesity
- (2013) Rodrigo Hernández Vera et al. THROMBOSIS AND HAEMOSTASIS
- Weight change, genetics and antiepileptic drugs
- (2013) Joseph Chukwu et al. Expert Review of Clinical Pharmacology
- The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors
- (2012) Giselle G. Hamad et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients
- (2012) Sweta Tandra et al. ANNALS OF SURGERY
- Impact of Obesity on Drug Metabolism and Elimination in Adults and Children
- (2012) Margreke J.E. Brill et al. CLINICAL PHARMACOKINETICS
- Drug Disposition in Pathophysiological Conditions
- (2012) Adarsh Gandhi et al. CURRENT DRUG METABOLISM
- The effects of gastric bypass surgery on drug absorption and pharmacokinetics
- (2012) Dion R Brocks et al. Expert Opinion on Drug Metabolism & Toxicology
- Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2012) Jennifer J. Griggs et al. JOURNAL OF CLINICAL ONCOLOGY
- A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution
- (2012) Adam S. Darwich et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Obesity and Diabetic Kidney Disease
- (2012) Christine Maric-Bilkan MEDICAL CLINICS OF NORTH AMERICA
- Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin
- (2012) Gunn Signe Jakobsen et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers
- (2012) Wendelin K Nelson et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Pharmacokinetic considerations in Roux-en-Y gastric bypass patients
- (2011) A. Smith et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Therapeutic drug monitoring to adjust dosing in morbid obesity - a new use for an old methodology
- (2011) Jennifer H. Martin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Anticoagulating obese patients in the modern era
- (2011) Jignesh P. Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Implications of Obesity for Drug Therapy: Limitations and Challenges
- (2011) R Jain et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
- (2011) A Astrup et al. INTERNATIONAL JOURNAL OF OBESITY
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Estimating the Glomerular Filtration Rate in Obese Adult Patients for Drug Dosing
- (2010) Manjunath P. Pai ADVANCES IN CHRONIC KIDNEY DISEASE
- Availability of information for dosing injectable medications in underweight or obese patients
- (2010) K. A. Jacques et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Dose adjustment of anaesthetics in the morbidly obese
- (2010) J Ingrande et al. BRITISH JOURNAL OF ANAESTHESIA
- Effect of Obesity on the Pharmacokinetics of Drugs in Humans
- (2010) Michael J. Hanley et al. CLINICAL PHARMACOKINETICS
- Dose-Dependent Delay of the Hypoglycemic Effect of Short-Acting Insulin Analogs in Obese Subjects With Type 2 Diabetes: A pharmacokinetic and pharmacodynamic study
- (2010) M. Gagnon-Auger et al. DIABETES CARE
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
- (2009) Daphne P Guh et al. BMC PUBLIC HEALTH
- Assessment methods in human body composition
- (2009) Seon Yeong Lee et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- The Medical Risks of Obesity
- (2009) Xavier Pi-Sunyer POSTGRADUATE MEDICINE
- Lean body mass normalizes the effect of obesity on renal function
- (2008) Sarayut Janmahasatian et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Management of Obesity in Adults: European Clinical Practice Guidelines
- (2008) Constantine Tsigos et al. Obesity Facts
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started